| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 26.557 | 29.976 | 28.523 | 25.539 | 28.927 | 27.684 | 26.610 | 24.326 | 19.463 |
| Total Income - EUR | 0 | 26.631 | 29.979 | 28.779 | 25.726 | 28.965 | 27.684 | 26.610 | 24.327 | 19.463 |
| Total Expenses - EUR | 0 | 9.444 | 6.421 | 7.457 | 5.395 | 6.550 | 11.816 | 11.710 | 21.589 | 17.251 |
| Gross Profit/Loss - EUR | 0 | 17.188 | 23.557 | 21.323 | 20.331 | 22.415 | 15.869 | 14.900 | 2.738 | 2.212 |
| Net Profit/Loss - EUR | 0 | 16.376 | 22.658 | 20.444 | 19.564 | 21.547 | 15.138 | 14.197 | 1.919 | 1.270 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neuroflux Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 2.937 | 4.376 | 2.800 | 3.108 | 1.855 | 28.557 | 23.270 | 18.294 | 11.487 |
| Current Assets | 157 | 17.316 | 33.725 | 46.999 | 60.399 | 77.706 | 78.629 | 78.525 | 73.564 | 75.959 |
| Inventories | 70 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 6.638 | 6.530 | 10.073 | 13.841 | 26.648 | 37.309 | 46.473 | 60.851 | 62.761 |
| Cash | 87 | 10.656 | 27.194 | 36.926 | 46.558 | 51.058 | 41.320 | 32.052 | 12.713 | 13.198 |
| Shareholders Funds | 45 | 16.420 | 34.192 | 49.485 | 63.262 | 79.257 | 87.318 | 96.197 | 90.133 | 82.176 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 112 | 3.833 | 3.909 | 314 | 246 | 303 | 19.868 | 15.921 | 11.951 | 8.764 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8551 - 8551" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Neuroflux Srl